ESC Congress 2026 Abstract
Dapagliflozin ameliorates arterial stiffness, endothelial glycocaclyx and myocardial performance in non-diabetic STEMI patients: a 3-month follow-up study
Non-randomized trial in 80 peopleDapagliflozin
23 papers2 new in 30 days